Aequs Limited (AEQUS) has reported impressive financial results for Q2 and H1 FY27, with a 50% year-over-year revenue growth to ₹8,046 Mn. This growth is primarily driven by the robust performance in the Aerospace segment, which saw a 42% YoY increase in revenue. The Company’s strong financial health is further evidenced by a 6% EBITDA margin for H1 FY27, up from 4% in Q2 FY27. Notably, the Aerospace order book has expanded to USD 1.1 billion, bolstered by the Safran A320 wheels agreement, marking Aequs’ first serial-production contract exceeding 15 years.

Robust Financial Performance

The Company’s EBITDA for H1 FY27 stood at ₹460 Mn, a significant improvement from ₹245 Mn in Q2 FY27. The PAT margin, although negative at -13%, reflects strategic investments aimed at long-term growth. Aequs continues to focus on disciplined execution and stronger returns, with a ₹6,500 Mn promoter warrant intended to support the next phase of expansion, including the Hosur facility.

Strategic Expansion and Leadership Changes

Aequs has also made strategic moves to strengthen its leadership and operational capabilities. Reenah Joseph has been appointed as the new CFO, bringing extensive experience in corporate finance and investor relations. Additionally, the Company has expanded its relationships with Safran, now covering six entities, and is replicating its successful Belagavi aerospace ecosystem at Hosur to further enhance its manufacturing scope.

As Aequs continues to expand its manufacturing capabilities and secure long-term partnerships, the focus remains on translating installed capacity into profitable growth and achieving disciplined execution for sustained returns.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Aequs Limited

Aequs Limited belongs to the Industrials › Aerospace & Defense sector. Here’s a quick read on where the business and the stock stand today.

Aequs rises 14.8% over three months, with buying pressure holding steady. Margins at 12.4% are middling — adequate but leaving the business with little buffer against cost shocks. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock trades at 82% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. Price climbs recently despite 14.8% revenue growth and a PEG of 99.00. Consequently, either institutions position ahead of improvement or the move fades when earnings disappoint. Treat this as a trading signal, not an investment thesis. Check Fundamentals of Aequs Limited.

Aequs Limited (AEQUS), a leading India-based precision manufacturing company, today announced the signing of long-term supply agreements with Safran, a global leader in the aerospace industry for critical components. These agreements reflect the commitment of both companies to strengthen their collaboration and highlight Safran’s dedication to working with trusted, high-quality industrial partners.

Strengthening Aerospace Collaboration

The contracts will support Safran’s supply chain and ongoing production programs, while also contributing to the growth and development of Aequs within the aerospace sector. This milestone represents a significant opportunity for Aequs to further expand its activities alongside one of the world’s leading aerospace companies.

Expanding Manufacturing Capabilities

The agreements build on Aequs’ longstanding engagement with Safran Landing Systems and extend the relationship to Safran Aerosystems, broadening the scope of collaboration. The awards cover the machining of superalloys parts, along with the supply of complex machining coating, and assembly of landing gear components for the Airbus A320, A330, A350, and Boeing 787 programs. Aequs will leverage its integrated aerospace manufacturing ecosystem and end-to-end capabilities across forging, precision machining, special processes, surface treatment, and assembly to manufacture these products.

As a result, the role of Aequs’ Belagavi Aerospace Cluster as an integrated manufacturing base serving global aerospace supply chains will be further strengthened. This capability base will be expanded with the upcoming Aequs Engine Components Ecosystem (AECE) in Hosur, Tamil Nadu, where the manufacture of all medium and large parts will be taken up.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Aequs Limited

Aequs Limited belongs to the Industrials › Aerospace & Defense sector. Here’s a quick read on where the business and the stock stand today.

Aequs rises 9.9% over three months, with buying pressure holding steady. Margins at 12.4% are middling — adequate but leaving the business with little buffer against cost shocks. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock trades at 88% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. Price climbs recently despite 14.8% revenue growth and a PEG of 99.00. Consequently, either institutions position ahead of improvement or the move fades when earnings disappoint. Treat this as a trading signal, not an investment thesis. Check Fundamentals of Aequs Limited.

Aequs Limited (AEQUS) has approved a preferential issue of up to 2,80,71,690 warrants, each convertible into one fully paid-up equity share of face value ₹10, to Mellwood Trustee Services Private Limited (Trustee of the Melligeri Private Family Foundation) (“Promoter”). This move aggregates to approximately ₹650 crore and is aimed at funding the company’s aerospace and consumer capacity expansion and supporting its borrowing program.

Significance of the Infusion

The proceeds from this infusion will fund capacity expansion across the aerospace and consumer businesses, including the development of the Hosur facility, investment in subsidiaries and joint ventures supporting that expansion, and general corporate purposes. The equity will also provide the base against which the company raises its term borrowings for the expansion. This infusion aligns the Promoter Group’s economic commitment with the company’s long-term growth plans and capital requirements.

Execution and Timeline

Of the total issue size of approximately ₹650 crore, ₹325 crore will be payable upfront upon allotment of the warrants, representing 50 per cent of the issue size, and twice the regulatory minimum. The balance will be payable upon exercise of the warrants. The warrants may be exercised within 18 months from the date of allotment. Conversion of warrants into equity shares, by making payment of balance consideration, shall take place on or before December 31, 2027. Promoter has undertaken to pay the balance consideration in full, irrespective of the market price of the company’s shares at the time of exercise.

An Extraordinary General Meeting is scheduled on Thursday, October 22, 2026, through video conferencing to seek shareholders’ approval. The detailed terms and conditions of the proposed issue, along with other relevant disclosures, will be made available to shareholders and filed with the stock exchanges in accordance with applicable laws and regulations.

Aravind Melligeri, Executive Chairman & CEO, Aequs Limited, said: “We are winning programmes faster than we had planned for, and those wins need investment ahead of the revenue they bring. This issue gives Aequs committed capital to build that capacity and the equity base to support the borrowing that goes with it. The Promoter Group is subscribing at the price as per SEBI pricing formula and paying half of it upfront — that is the measure of our confidence in what this business can deliver.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Aequs Limited

Aequs Limited belongs to the Industrials › Aerospace & Defense sector. Here’s a quick read on where the business and the stock stand today.

Aequs posts a 7.5% three-month gain, but softens in the last few weeks. Margins at 12.4% are middling — adequate but leaving the business with little buffer against cost shocks. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock gives back 2.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The stock holds up despite 14.8% revenue growth and a PEG of 99.00. That could signal an early turnaround. Alternatively, index flows simply support the price. Watch whether analysts revise estimates upward — that is the real signal. Check Fundamentals of Aequs Limited.